High Prolactin or PCOS? Why Both Stop Your Periods and How Tests Tell Them Apart

Why hyperprolactinaemia and PCOS get confused

Both conditions stop periods by interrupting the same relay. Prolactin, when elevated, suppresses the pulsatile release of GnRH, which in turn lowers LH and FSH and stops ovulation — a direct, single-hormone mechanism. PCOS reaches the same endpoint by a more roundabout route: excess androgens and, in most phenotypes, insulin resistance disrupt the same signalling loop from a different direction. The visible result — irregular or absent periods — looks identical from the outside even though the two starting points have nothing in common.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same mechanism — only the label changed. This article uses PCOS, since that is still the term most readers search.

This question sits alongside two related ones worth checking at the same time: PCOS vs endometriosis and PCOS vs Cushing’s syndrome cover the other conditions that produce enough of the same picture to need their own test rather than an assumption.

What actually separates them, feature by feature

The two conditions share one symptom — disrupted periods — and diverge everywhere else, including on the one sign PCOS never produces: spontaneous nipple discharge.

Prolactinoma vs PCOS: the sign that PCOS cannot produce

Galactorrhea is the single most useful discriminator on this list, because PCOS has no mechanism that produces it. Prolactinomas — benign pituitary tumours that account for 32% to 66% of all pituitary adenomas — are the single most common cause of persistently high prolactin, and they present with exactly the combination that PCOS does not: amenorrhea or irregular cycles alongside spontaneous nipple discharge, and in men, low libido and erectile dysfunction. Pituitary adenomas overall affect between 1 in 865 and 1 in 2,688 adults — uncommon, but nowhere near as rare as Cushing’s disease, and common enough that a prolactin level belongs in a routine PCOS-suspected work-up rather than being reserved for unusual cases.

Headache or a change in peripheral vision is a different kind of clue: it points toward tumour size rather than tumour type, since it only appears once a prolactinoma is large enough (generally 10mm or more, a macroprolactinoma) to press on the structures around the pituitary gland. Most prolactinomas are smaller microadenomas that never reach this stage.

What the prolactin level itself tells you

The size of the elevation narrows the cause before any imaging happens. A prolactin level above 250 ng/mL is highly suggestive of a prolactinoma and effectively rules out a non-functioning pituitary tumour or macroprolactinemia as the cause, while levels under 100 ng/mL are more typical of drug-induced hyperprolactinaemia, macroprolactin, or a non-secreting tumour pressing on the pituitary stalk. The rule has real exceptions — up to 25% of people with a small or cystic prolactinoma still test under 100 ng/mL — so a moderate result does not rule a prolactinoma out on its own.

One further pitfall is worth knowing before ordering an MRI on the strength of a single number. Very large tumours can occasionally produce a falsely low or normal prolactin reading, called the hook effect, caused by the assay itself being overwhelmed at very high concentrations. It is unmasked by diluting the serum sample 1:100 and re-testing — worth requesting specifically if a visibly large pituitary mass on imaging does not match a surprisingly modest prolactin result.

The pitfall almost everyone misses: macroprolactin

Before any of the above matters, the lab needs to rule out that the “high prolactin” is not real prolactin at all. Macroprolactin is a larger, less bioactive prolactin complex that gets measured by standard assays as if it were the active hormone. In one study of 102 people with a prolactin level above 100 ng/mL, macroprolactin accounted for 21.6% of the cases, and it is now recognised as the third most common cause of a raised prolactin result, after medication and true prolactinomas. Screening for it uses a simple polyethylene glycol (PEG) precipitation step added onto the same blood sample.

This matters because macroprolactin is not inert for everyone. In the same study, 72.7% of confirmed macroprolactinemia cases still had a reproductive symptom — irregular cycles, infertility, or galactorrhea — which means a macroprolactin result does not automatically close the question the way it is sometimes treated. It does, however, mean an MRI and a prolactinoma diagnosis are very likely the wrong next step until macroprolactin has specifically been excluded.

The test that actually tells them apart

For PCOS, the 2023 international guideline specifies an androgen panel plus a pelvic ultrasound or AMH level, applied once other causes of the same picture — including hyperprolactinaemia — have been excluded. For high prolactin, the 2011 Endocrine Society guideline recommends a single fasting morning prolactin level as the starting test, repeated if mildly elevated, since stress, a recent breast exam, or even the blood draw itself can transiently raise the number. A result that stays elevated on repeat is followed by ruling out pregnancy, primary hypothyroidism, and medication as causes, then a macroprolactin screen if the level and symptoms do not match, then a pituitary MRI if a true, unexplained elevation remains.

What this does not explain

A single mildly elevated prolactin drawn during a stressful or rushed visit, with a normal repeat result and no galactorrhea, headache, or visual change, is not evidence of a prolactin-driven cause for irregular cycles — it is a common false alarm. In that situation, the irregular cycles still need their own explanation, and PCOS’s own diagnostic blood panel is the more useful next step than repeating prolactin a third time. The reverse also holds: irregular periods with no androgen signs at all are a reason to check prolactin before assuming PCOS, not after.

Your next step

Ask for a single fasting morning prolactin level alongside the standard PCOS panel — testosterone, LH, FSH, and a pelvic ultrasound — rather than waiting to see if cycles regulate on their own. If the prolactin result comes back mildly elevated, ask specifically whether a macroprolactin screen was included before agreeing to an MRI; if it comes back sharply elevated or you have galactorrhea or headaches, ask for the pituitary MRI directly. For the rest of the exclusion list the 2023 guideline requires before a PCOS diagnosis is confirmed, the full work-up, test by test, covers it in order.